FEDERICO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 77.320
EU - Europa 34.850
AS - Asia 27.551
SA - Sud America 4.169
Continente sconosciuto - Info sul continente non disponibili 1.729
AF - Africa 775
OC - Oceania 205
Totale 146.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 75.536
GB - Regno Unito 11.248
IT - Italia 7.716
SG - Singapore 7.253
CN - Cina 7.013
RU - Federazione Russa 3.675
HK - Hong Kong 3.324
BR - Brasile 3.124
VN - Vietnam 2.985
DE - Germania 2.619
SE - Svezia 2.573
FI - Finlandia 1.731
BD - Bangladesh 1.679
TR - Turchia 1.473
UA - Ucraina 1.453
FR - Francia 1.285
CA - Canada 908
KR - Corea 770
IN - India 593
BG - Bulgaria 546
JP - Giappone 464
NL - Olanda 393
ID - Indonesia 376
AR - Argentina 335
IE - Irlanda 277
MX - Messico 261
IQ - Iraq 208
ZA - Sudafrica 205
ES - Italia 200
AU - Australia 185
AE - Emirati Arabi Uniti 172
PK - Pakistan 170
EC - Ecuador 154
CO - Colombia 149
PL - Polonia 146
BE - Belgio 142
AT - Austria 138
CL - Cile 138
MY - Malesia 137
MA - Marocco 129
BZ - Belize 110
CZ - Repubblica Ceca 105
EG - Egitto 103
SA - Arabia Saudita 100
CR - Costa Rica 95
CH - Svizzera 92
VE - Venezuela 92
PH - Filippine 87
RO - Romania 86
JM - Giamaica 80
UZ - Uzbekistan 80
IL - Israele 75
IR - Iran 75
LT - Lituania 69
TH - Thailandia 68
TN - Tunisia 68
NP - Nepal 63
TW - Taiwan 59
DZ - Algeria 56
KE - Kenya 56
PY - Paraguay 49
GT - Guatemala 47
PE - Perù 47
JO - Giordania 45
TT - Trinidad e Tobago 45
PT - Portogallo 43
AZ - Azerbaigian 41
UY - Uruguay 40
DK - Danimarca 39
HN - Honduras 38
SV - El Salvador 38
NI - Nicaragua 33
BO - Bolivia 32
DO - Repubblica Dominicana 30
HU - Ungheria 30
NO - Norvegia 30
EU - Europa 29
KZ - Kazakistan 28
PR - Porto Rico 27
ET - Etiopia 26
GR - Grecia 26
OM - Oman 26
EE - Estonia 25
KG - Kirghizistan 24
LB - Libano 20
PA - Panama 20
RS - Serbia 19
SC - Seychelles 19
BH - Bahrain 17
NZ - Nuova Zelanda 17
AL - Albania 16
AM - Armenia 16
LY - Libia 16
SK - Slovacchia (Repubblica Slovacca) 16
HR - Croazia 15
LV - Lettonia 15
MD - Moldavia 15
SI - Slovenia 15
BY - Bielorussia 14
AO - Angola 13
Totale 144.603
Salva come PNG Salva come JPEG
Città #
Ashburn 9.515
Southend 8.520
Fairfield 6.448
Santa Clara 5.082
Singapore 4.515
Woodbridge 3.562
Hong Kong 3.200
Houston 2.987
Chandler 2.930
San Jose 2.841
Moscow 2.715
Jacksonville 2.651
Seattle 2.457
Council Bluffs 2.325
Wilmington 2.286
Dearborn 2.119
Cambridge 2.087
Hefei 2.032
Ann Arbor 1.640
Beijing 1.421
Nyköping 1.349
Los Angeles 1.334
London 1.319
Helsinki 1.206
Chicago 990
Ho Chi Minh City 895
New York 883
The Dalles 855
Izmir 783
Milan 754
Hanoi 657
Frankfurt am Main 650
San Diego 641
Princeton 602
Seoul 587
Buffalo 556
Dallas 530
Sofia 528
Eugene 477
Modena 474
Rome 443
Lauterbourg 396
Columbus 384
São Paulo 354
Shanghai 347
Salt Lake City 338
Phoenix 310
Redwood City 308
Des Moines 281
Jakarta 263
Atlanta 242
Boardman 239
Tokyo 231
Dublin 223
Toronto 223
Munich 218
Dong Ket 206
North Bergen 176
Orem 171
Bremen 169
Bologna 167
San Francisco 163
Denver 153
Brooklyn 151
Elk Grove Village 150
Falls Church 144
Naples 141
Montreal 140
Tampa 138
Miami 135
Turin 134
Da Nang 129
Philadelphia 125
Haiphong 116
Manchester 116
Verona 111
Norwalk 110
Belize City 107
Las Vegas 105
Rio de Janeiro 103
Warsaw 99
Guangzhou 92
Boston 91
Florence 91
Chennai 89
Washington 88
Brussels 86
Nuremberg 86
Palermo 85
Mexico City 84
Padova 83
Amsterdam 80
Johannesburg 79
Brno 77
Sterling 77
Stockholm 75
Kunming 74
Lancaster 71
Baghdad 70
Miano 69
Totale 97.209
Salva come PNG Salva come JPEG
Nome #
Clinical activity and safety of combination immunotherapy with interferon-(2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. 2.960
SPLENECTOMY AFTER INITIAL THERAPY WITH ALPHA-IFN IN PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL) - A MULTICENTER STUDY BY THE ITALIAN COOPERATIVE GROUP FOR HCL - PRELIMINARY-RESULTS 2.665
Hb Hasharon: studio di un nucleo familiare 1.538
Eritropoiesi extramidollare intratoracica. Considerazioni clinico radiologiche su due casi di talassemia minor 1.185
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12 1.177
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial 965
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 836
Cancer profile in Eastern Libya: incidence and mortality in the year 2004. 802
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial 795
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin 785
Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003 766
Estimates of cancer burden in Italy 732
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi 730
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 711
Pattern of cancer risk in person with AIDS in Italy inthe HAART era 708
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma 648
IMPACT Working Group: effectiveness of service screening: a case-control study to assess breast cancer mortalità reduction. 622
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 594
Caratterizzazione morfo-funzionale delle cellule reticolari dendritiche. 591
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients 569
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. 567
Il linfoma mantellare 554
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients 550
T-cell lymphoma in South America and Europe. 534
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 519
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project 508
Transformed follicular lymphoma 508
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 505
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias. 504
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women 503
Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial 487
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 486
Follicular lymphoma international prognostic index. 467
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 458
Splenic marginal zone lymphoma: a prognostic model for clinical use. 456
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study 451
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 435
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma 434
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma - The experience of the gruppo italiano studio linfomi 433
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions. 427
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy 425
Use of 2-(18F)fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy 419
Revised response criteria for malignant lymphoma. 413
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations 411
Prognosis and treatment of micrometastatic breast cancer sentinel lymph node: a population-based study. 410
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 408
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients 406
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project 401
Treatment of indolent B-cell nonfollicular lymphomas: Final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi 395
Protein expression patterns associated with advanced stage ovarian cancer 394
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 392
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 390
Patologia non neoplastica del follicolo linfatico 389
PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract 385
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy 384
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience 383
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. 383
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 382
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat 380
Prognosis of follicular lymphomas 379
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfom 379
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: Final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi 377
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 374
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) 374
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? 370
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: Results from a study of the Fondazione Italiana Linfomi 367
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 367
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies 366
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis 364
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 363
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 361
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study 359
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: Results of a prospective, multicenter study of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 358
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project 358
Anthracyclines: A cornerstone in the management of non-Hodgkin's lymphoma 356
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma 354
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 353
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study 353
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 351
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 351
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi 350
Efficacy Controls and Long-Term Follow-Up of Patients (Pts) Treated with FC Plus Rituximab for Relapsed Follicular NHL. Session Type: Publication Only 349
Concordance between four European centre of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. 349
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-cell Lymphoma Project 348
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: Results of a large multicenter study involving 990 patients 347
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network 344
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project 342
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 341
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. 341
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 340
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 340
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. 340
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. 339
PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study 339
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 338
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi 337
Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes 337
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 337
Cancer incidence, mortality, and survival in Eastern Libya: Updated report from the Benghazi Cancer Registry 335
Role of Glutathione-S-Transferase (GST) polymorphisms in patients with advanced Hodgkin Lymphoma: results from the HD2000 GISL Trial 334
Totale 52.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 513.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 513.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.304 0 0 0 792 318 521 593 608 1.062 702 1.647 1.061
2022/20239.552 1.028 902 642 808 1.197 1.459 252 1.007 1.215 176 504 362
2023/20247.778 329 432 421 538 1.586 462 810 1.161 160 284 698 897
2024/202520.415 1.371 985 282 1.358 3.603 2.583 1.651 1.112 2.432 716 1.892 2.430
2025/202640.137 2.134 1.579 3.222 3.757 5.055 2.794 4.330 1.997 3.475 3.255 4.296 4.243
2026/202712.021 1.717 2.448 3.079 4.777 0 0 0 0 0 0 0 0
Totale 146.599